1. Home
  2. LFMD vs EBS Comparison

LFMD vs EBS Comparison

Compare LFMD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • EBS
  • Stock Information
  • Founded
  • LFMD 1994
  • EBS 1998
  • Country
  • LFMD United States
  • EBS United States
  • Employees
  • LFMD N/A
  • EBS N/A
  • Industry
  • LFMD Medical/Nursing Services
  • EBS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMD Health Care
  • EBS Health Care
  • Exchange
  • LFMD Nasdaq
  • EBS Nasdaq
  • Market Cap
  • LFMD 480.8M
  • EBS 393.9M
  • IPO Year
  • LFMD N/A
  • EBS 2006
  • Fundamental
  • Price
  • LFMD $13.25
  • EBS $6.32
  • Analyst Decision
  • LFMD Strong Buy
  • EBS Strong Buy
  • Analyst Count
  • LFMD 6
  • EBS 3
  • Target Price
  • LFMD $11.17
  • EBS $14.33
  • AVG Volume (30 Days)
  • LFMD 1.9M
  • EBS 1.4M
  • Earning Date
  • LFMD 05-06-2025
  • EBS 05-07-2025
  • Dividend Yield
  • LFMD N/A
  • EBS N/A
  • EPS Growth
  • LFMD N/A
  • EBS N/A
  • EPS
  • LFMD N/A
  • EBS N/A
  • Revenue
  • LFMD $234,007,330.00
  • EBS $965,400,000.00
  • Revenue This Year
  • LFMD $29.64
  • EBS N/A
  • Revenue Next Year
  • LFMD $17.90
  • EBS $16.07
  • P/E Ratio
  • LFMD N/A
  • EBS N/A
  • Revenue Growth
  • LFMD 43.07
  • EBS N/A
  • 52 Week Low
  • LFMD $3.99
  • EBS $4.02
  • 52 Week High
  • LFMD $12.93
  • EBS $15.10
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 88.41
  • EBS 55.73
  • Support Level
  • LFMD $11.02
  • EBS $6.17
  • Resistance Level
  • LFMD $12.19
  • EBS $6.49
  • Average True Range (ATR)
  • LFMD 0.89
  • EBS 0.37
  • MACD
  • LFMD 0.16
  • EBS -0.02
  • Stochastic Oscillator
  • LFMD 100.00
  • EBS 59.06

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Share on Social Networks: